Biofeedback in treatment of aggressio
- Conditions
- This research project will be performed among forensic outpatients with a proven lack of anger management skillscaused by different psychiatric disorders according to DSM-V criteria.
- Registration Number
- NL-OMON21893
- Lead Sponsor
- ot applicable
- Brief Summary
ot applicable (yet)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 24
1. Proven lack of anger management skills, indicated by either a recently committed violent crime and/or a high risk of committing one;
2. Assigned to individual outpatient Aggression Regulation Treatment after multidisciplinary consultation;
3. Basic understanding of mobile applications;
4. Aged 16 years or above.
1. Acute manic or psychotic symptoms according to the clinician and/or DSM-V criteria as measured with the (revised) Mini International Neuropsychiatric Interview (MINI), indicated by a score of 3 (or higher) on item 6 or addendum item 1 of the Health of the Nations Outcome Scales (HoNOS);
2. Current high risk of suicide requiring immediate intervention according to the clinician and/or DSM-V criteria as measured with the MINI, indicated by a score of 3 (or higher) on item 2 of the HoNOS;
3. Severe addiction problems, indicated by a score of 4 on the HoNOS, or severe conditions requiring immediate intervention or hospitalisation;
4. Insufficient understanding of the spoken and written Dutch language.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psychophysiological awareness and aggression-related concepts during the ABA-design (baseline, intervention, and follow-up phase using Ecological Momentary Assesment) and at T1 by use of the Agression Questionnaire (AQ) and Anger Bodily Sensations Questionnaire (ABSQ). Also, physiological measures (heart rate) are measured during the ABA-design (baseline, intervention and follow-up).
- Secondary Outcome Measures
Name Time Method Secondary measures, such as anger and aggression (e.g. STAXI-2), emotion regulation (DERS), psychiatric functioning (HoNOS), will be assessed before and after the four-week ABA-period (T1); and some also at 1 month follow-up (Tf). Also, the system usability of the biofeedback will be evaluated at T1, both quantitatively and qualitatively. At T0, several other outcomes will be assessed to describe the sample, such as aggression type (RPQ), psychopathy (YPI-s) and demographic information.